Goldmann-Favre vitreoretinal degeneration.
Batioğlu F.
Eur J Ophthalmol. 2003 Apr;13(3):307-10. doi: 10.1177/112067210301300311.
[Goldmann-Favre hyaloido-tapetoretinal degeneration].
Fiore C, Ricci A.
Arch Ophtalmol (Paris). 1976 Feb;36(2):127-36.
[Clinical features of Goldmann-Favre vitreoretinal degeneration].
Herrador-Montiel Á, Sánchez-Vicente JL, Arias-Alcalá M.
Arch Soc Esp Oftalmol. 2012 Aug;87(8):260-2. doi: 10.1016/j.oftal.2011.11.018. Epub 2012 Mar 21.
Goldmann-Favre maculopathy.
Nasr YG, Cherfan GM, Michels RG, Wilkinson CP.
Retina. 1990;10(3):178-80.
Recognizable Patterns of Submacular Fibrosis in Enhanced S-Cone Syndrome.
Alsalamah AK, Khan AO, Bakar AA, Schatz P, Nowilaty SR.
Ophthalmol Retina. 2021 Sep;5(9):918-927. doi: 10.1016/j.oret.2021.03.014. Epub 2021 Apr 2.
Clinical features of Goldmann-Favre syndrome.
Ikäheimo K, Tuppurainen K, Mäntyjärvi M.
Acta Ophthalmol Scand. 1999 Aug;77(4):459-61. doi: 10.1034/j.1600-0420.1999.770422.x.
Relatively enhanced S cone function in the Goldmann-Favre syndrome.
Jacobson SG, Román AJ, Román MI, Gass JD, Parker JA.
Am J Ophthalmol. 1991 Apr 15;111(4):446-53. doi: 10.1016/s0002-9394(14)72379-7.
[Study of vitreoretinal dystrophies in a Mexican population].
Orozco-Gómez LP, Castellanos-Pérez Bolde CG, Moguel-Ancheita S, Lambarri-Arroyo A.
Cir Cir. 2008 Jan-Feb;76(1):13-21.
[Goldmann-Favre syndrome--case report].
Brydak-Godowska J, Makowiec-Tabernacka M.
Klin Oczna. 2009;111(10-12):346-7.
[Vitreo-retinal degeneration of Goldmann-Favre (author's transl)].
Dróbecka-Brydakowa E, Szewczyk-Bocheńska N, Dyszynska-Rościszewska B.
Klin Oczna. 1977 Jun;47(6):275-6.
